Decreased expression of SIRT3 and other key mitochondrial proteins involved in fatty acid oxidation and OXPHOS suggest mitochondrial dysfunction may precede more detrimental obesity associated co-morbidities such as insulin resistance and NAFLD. Here, SIRT3 is linked to metabolic dysfunction-associated steatotic liver disease.